BioSpace News Archive

Deals

Hua Medicine Selected for Inclusion in the MSCI Hong Kong Micro Cap Index

Hua Medicine, a leading innovative drug development company focused on developing novel therapies for the treatment of diabetes, is pleased to announce that the Company has been officially included as a constituent stock of the MSCI Hong Kong Micro Cap Index.

May 31, 2020
·
3 min read
Innovent Biologics Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Relapsed or Refractory Extranodal NK/T-Cell Lymphoma (Nasal Type)

Innovent Biologics, Inc. announced the two-year follow-up results of TYVYT® ORIENT-4 study in relapsed or refractory Extranodal NK/T-cell lymphoma at the 56th Annual Meeting of the American Society of Clinical Oncology .

May 31, 2020
·
4 min read
Pharm Country

Taiho Oncology Announces Presentation of Data for Futibatinib in Advanced Intrahepatic Cholangiocarcinoma at 2020 ASCO Meeting

Taiho Oncology, Inc. announced efficacy and safety results of an interim analysis of FOENIX-CCA2, a single-arm multicenter Phase 2 study evaluating futibatinib in patients with intrahepatic cholangiocarcinoma harboring FGFR2 gene fusions or other rearrangements, who have failed at least one line of therapy.

May 31, 2020
·
4 min read
Policy

Minister of Health announces funding for projects to help Canadians stop tobacco use

Tobacco is the leading preventable cause of premature death and disease in Canada.

May 31, 2020
·
6 min read